Ostertagia ostertagi: Comprehensive Reference on Bovine Ostertagiosis

Introduction

Ostertagia ostertagi, commonly known as the brown stomach worm, is a highly prevalent abomasal nematode of cattle worldwide and a major cause of production losses in grazing herds [1, 2]. The parasite induces a spectrum of disease from subclinical growth impairment to severe gastroenteritis, termed ostertagiosis [1, 3]. Understanding its biology, epidemiology, and host interactions is critical for designing effective control programs, particularly in the face of emerging anthelmintic resistance [4, 5, 6]. This article provides a detailed reference on O. ostertagi for veterinary professionals, diagnosticians, and computational biologists.

Taxonomy and Morphology

O. ostertagi belongs to the family Trichostrongylidae, order Strongylida [1]. Adult worms are slender, reddish-brown, and measure 6–9 mm in length. Males possess a prominent copulatory bursa with two spicules, while females have a vulval flap and produce thin-shelled, morulated eggs (approximately 70–90 µm by 35–45 µm) [1]. The third-stage larvae (L3) are the infective stage, ensheathed and resistant to environmental extremes [1, 7].

Life Cycle

The life cycle is direct, with a free-living phase on pasture and a parasitic phase within the bovine abomasum [1, 8]. Eggs are passed in feces and develop through first (L1) and second (L2) larval stages to the infective L3 within 1–3 weeks under favorable conditions [1]. L3 migrate onto herbage and are ingested by grazing cattle. After ingestion, exsheathment occurs in the rumen, and L3 penetrate the abomasal mucosa, molting to L4 and then to adults [1, 7]. Adults emerge onto the mucosal surface, where they feed on tissue fluids and produce eggs [1]. The prepatent period is approximately 18–21 days [1].

A key feature is hypobiosis (arrested development) at the early L4 stage, triggered by environmental cues such as decreasing temperature or seasonal changes [1, 4, 9]. Hypobiotic larvae can resume development months later, contributing to type II ostertagiosis [1, 10].

graph TD
    A[Adult worms in abomasum], > B[Eggs in feces]
    B, > C[L1 larvae in feces]
    C, > D[L2 larvae]
    D, > E[L3 infective larvae on pasture]
    E, > F[Ingestion by cattle]
    F, > G[Exsheathment in rumen]
    G, > H[L3 penetrate abomasal mucosa]
    H, > I[L4 larvae in mucosa]
    I, > J[Adult worms emerge]
    J, > A
    I, > K[Hypobiotic L4 arrested development]
    K, > I

Epidemiology

O. ostertagi is distributed globally in temperate and subtropical regions [1, 2, 11]. Infection prevalence in dairy herds is high; serological surveys using bulk tank milk ELISA have demonstrated widespread exposure across Europe [12]. In Norway, a cross-sectional study found high variability in individual antibody ODR values within herds, with bulk tank milk ODR useful only for herds with very high or low exposure [13]. Seasonal dynamics show peak larval availability on pasture in late summer and autumn, with hypobiosis during winter [2, 14]. In Hokkaido, Japan, fecal egg counts decreased in winter and increased in warmer months, with O. ostertagi dominating coprocultures in autumn [2]. Risk factors include high stocking rate, continuous grazing, and lack of anthelmintic treatment history [15, 14].

Pathogenesis and Clinical Signs

Pathogenesis results from abomasal mucosal damage caused by emerging L4 and adult worms [1, 16]. The parasite induces hyperplasia of mucus-secreting cells, loss of parietal cells, and increased abomasal pH, leading to hypergastrinemia and elevated plasma pepsinogen levels [17, 16, 18]. These changes impair protein digestion and reduce feed intake [16, 3]. Clinical ostertagiosis is classified into type I (acute) and type II (chronic). Type I occurs in first-season grazers with high L3 intake, presenting with diarrhea, weight loss, anorexia, and hypoproteinemia [1, 19]. Type II results from synchronous emergence of hypobiotic larvae, causing severe abomasitis and high mortality [1, 10]. Subclinical infections are more common and cause reduced weight gain and milk production [2, 20, 21].

Transcriptomic analyses of abomasal mucosa reveal that infection elicits host immune responses but also induces immunosuppressive pathways, including T cell exhaustion, which may explain slow development of protective immunity [22]. Peripheral blood mononuclear cell transcriptomics show stage-specific immune reactions [23]. The rumen microbiome is also altered; subclinical infection enriches opportunistic pathogens like Listeria and depletes Filifactor, while affecting methane metabolism pathways [24].

Diagnosis

Diagnosis relies on a combination of methods. Fecal egg count (FEC) using modified McMaster or FLOTAC techniques detects eggs, but sensitivity is low in low-shedding animals [13, 25]. Coproculture and larval differentiation are required to speciate O. ostertagi from other strongyles [4]. Serological diagnosis using indirect ELISA to detect anti-O. ostertagi antibodies in serum, milk, or bulk tank milk is widely used for herd-level exposure assessment [13, 26, 20, 12]. The optical density ratio (ODR) correlates with infection intensity and can predict milk production response to anthelmintic treatment [26, 20]. Plasma pepsinogen levels are elevated in abomasal damage and serve as a biomarker [17]. Coproantigen detection by ELISA offers an alternative for patent infections [25].

Molecular diagnostics include quantitative PCR (qPCR) targeting L1 larvae for species identification and detection of anthelmintic resistance alleles [27, 5]. ITS-2 rDNA nemabiome metabarcoding integrated with FECRT provides species- and stage-specific resistance profiles [4]. Transcriptome analysis of different life stages has identified stage-specific gene expression, enabling development of molecular markers [7].

Anthelmintic Resistance

Resistance in O. ostertagi is a growing concern. Ivermectin resistance has been confirmed in New Zealand, western Canada, and the western United States [4, 6, 28]. In New Zealand, FECRT and controlled efficacy trials showed ivermectin efficacy as low as 13% against O. ostertagi, while moxidectin remained >99% effective [6]. In western Canada, ivermectin treatment resulted in 82.4% FECR at 14 days, but recrudescence of O. ostertagi L3 in coprocultures 3–6 months post-treatment indicated resistance in hypobiotic larvae [4]. Fenbendazole resistance has been documented in a field isolate from the UK, with 0% efficacy in a controlled test and high frequency of F200Y and F167Y SNPs in the β-tubulin isotype 1 gene [5]. Rapid selection for F200Y alleles on pasture has been demonstrated [29]. Dual resistance to macrocyclic lactones and albendazole has been reported [6]. Levamisole has historically shown variable efficacy against O. ostertagi [30]. Monitoring resistance requires integration of FECRT with molecular tools [27, 4, 5].

Control Strategies

Control relies on integrated pasture management and strategic anthelmintic use. Targeted selective treatment (TST) based on individual animal performance (e.g., average daily gain) can reduce selection for resistance while maintaining productivity [15]. Stochastic models indicate that stocking rate has a larger impact on parasitological outcomes than initial pasture contamination [8]. The "dose and move" strategy, where calves are treated and moved to clean pasture, is effective but may select for resistance [8]. Repeated drug-truncated infections (rDTI) have been used experimentally to induce partial protective immunity, suggesting potential for vaccination [31]. Vaccination with whole worm or excretory-secretory antigens elicits humoral and cell-mediated responses and reduces fecal egg counts [24, 31]. However, no commercial vaccine is currently available.

Economic Impact

Economic losses from O. ostertagi arise from reduced weight gain, decreased milk yield, and treatment costs. In German dairy herds, modeling using Paracalc estimated significant annual losses per cow [21]. In Europe, bulk tank milk antibody levels are associated with milk production losses [20, 12]. Subclinical infections in lactating cows reduce milk yield even when fecal egg counts are negative [2].

Frequently Asked Questions

What is the prepatent period of Ostertagia ostertagi?

The prepatent period is approximately 18 to 21 days from ingestion of L3 to appearance of eggs in feces [1].

How does hypobiosis affect disease presentation?

Hypobiosis is an arrested development at the early L4 stage, triggered by seasonal cues [1, 9]. Synchronous resumption of development leads to type II ostertagiosis, characterized by severe abomasitis and high mortality, often occurring in winter or early spring [1, 10].

Which diagnostic method is most sensitive for herd-level exposure?

Bulk tank milk ELISA measuring anti-O. ostertagi antibodies is widely used for herd-level surveillance, but it has poor predictive ability for individual animal ODR values [13, 12]. For individual diagnosis, serum or milk ELISA combined with fecal egg count is recommended [13, 26].

What anthelmintic resistance mechanisms are known in O. ostertagi?

Resistance to macrocyclic lactones (ivermectin, moxidectin) and benzimidazoles (fenbendazole, albendazole) has been confirmed [4, 5, 6, 28]. Benzimidazole resistance is associated with SNPs F167Y, E198A, and F200Y in the β-tubulin isotype 1 gene [5, 29]. Ivermectin resistance in hypobiotic larvae has been demonstrated via recrudescence after treatment [4].

Can cattle develop protective immunity against O. ostertagi?

Protective immunity develops slowly and is often incomplete [1, 22]. Repeated drug-truncated infections can induce partial protection with strong humoral and cell-mediated responses [31]. Transcriptomic data suggest parasite-induced immunosuppression, including T cell exhaustion, hinders immunity [22].

What is the role of the rumen microbiome in O. ostertagi infection?

Subclinical infection alters the rumen microbiome, enriching opportunistic pathogens like Listeria and depleting Filifactor [24]. Methane metabolism pathways are affected, and vaccination partially reverses some microbial changes [24].

How is anthelmintic resistance monitored in O. ostertagi?

Resistance is monitored using the fecal egg count reduction test (FECRT) combined with coproculture and larval differentiation [4, 6]. Molecular methods such as ITS-2 rDNA nemabiome metabarcoding and qPCR for resistance-associated SNPs enhance detection [27, 4, 5].

References

[1] Smith G, Grenfell BT. The population biology of Ostertagia ostertagi. Parasitology Today. 1985. https://www.semanticscholar.org/paper/3bd53e0ea30a75d6a9a17eee6e83543f64fe979b

[2] Ikeda K, Asakura Y, Fukumoto S, et al. Seasonal dynamics of Ostertagia ostertagi infection in lactating Holstein-Friesian cows on a dairy farm in Hokkaido, Japan. Acta Vet Hung. 2025. https://www.semanticscholar.org/paper/46d2c6e5dfc5f3ea32f697bd241d193498ffa4bf

[3] Fox MT, Gerrelli D, Pitt SR, et al. Ostertagia ostertagi infection in the calf: effects of a trickle challenge on appetite, digestibility, rate of passage of digesta and liveweight gain. Res Vet Sci. 1989. https://www.semanticscholar.org/paper/681e22683455e33c656b670123bc761206071d6d

[4] De Seram ED, Uehlinger F, de Queiroz C, et al. Integration of ITS-2 rDNA nemabiome metabarcoding with Fecal Egg Count Reduction Testing (FECRT) reveals ivermectin resistance in multiple gastrointestinal nematode species, including hypobiotic Ostertagia ostertagi, in western Canadian beef cattle. Int J Parasitol Drugs Drug Resist. 2023. https://www.semanticscholar.org/paper/91e6fa471df16ef301ed210c1d8a5047204c1da1

[5] Bartley DJ, Jewell N, Andrews L, et al. Molecular and phenotypic characterisation of fenbendazole resistance in a field-derived isolate of Ostertagia ostertagi. Vet Parasitol. 2020. https://www.semanticscholar.org/paper/ec93cd0311220b9e5a23b27a0b182f1803bf827e

[6] Waghorn TS, Miller CM, Leathwick DM. Confirmation of ivermectin resistance in Ostertagia ostertagi in cattle in New Zealand. Vet Parasitol. 2016. https://www.semanticscholar.org/paper/ead1f47e511d02f15d2738c25a5a6048c14884cb

[7] Heizer E, Zarlenga D, Rosa B, et al. Transcriptome analyses reveal protein and domain families that delineate stage-related development in the economically important parasitic nematodes, Ostertagia ostertagi and Cooperia oncophora. BMC Genomics. 2013. https://www.semanticscholar.org/paper/31d049e80aa44a95d205e390959b547dbf0d477b

[8] Berk Z, Laurenson Y, Forbes A, et al. A stochastic model to investigate the effects of control strategies on calves exposed to Ostertagia ostertagi. Parasitology. 2016. https://www.semanticscholar.org/paper/f85d2487121683947d19e656be18252214dbec1b

[9] Prichard RK, Donald AD, Hennessy DR. The effect of corticosteroid treatment on the development of inhibited Ostertagia ostertagi larvae. Res Vet Sci. 1974. https://www.semanticscholar.org/paper/ec42ccd1cea3c27656747da2650d4c14769d2ea3

[10] Holtenius P, Uggla A, Mayer E. Differences in effect on inhibited fourth stage Ostertagia ostertagi larvae after treatment in the beginning and in the middle of the stable period. 1980. https://www.semanticscholar.org/paper/7debcac8953f304c300957885b67bbec70119529

[11] Frey CF, Eicher R, Raue K, et al. Apparent prevalence of and risk factors for infection with Ostertagia ostertagi, Fasciola hepatica and Dictyocaulus viviparus in Swiss dairy herds. Vet Parasitol. 2018. https://www.semanticscholar.org/paper/741c0e902ae16285a256eda310e8c19061be21f1

[12] Forbes AB, Vercruysse J, Charlier J. A survey of the exposure to Ostertagia ostertagi in dairy cow herds in Europe through the measurement of antibodies in milk samples from the bulk tank. Vet Parasitol. 2008. https://www.semanticscholar.org/paper/6b0a217025e75fb7e6203489319101f747d36afa *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[13] Opsal T, Toftaker I, Robertson LJ, et al. Comparison of diagnostic methods for assessment of Ostertagia ostertagi exposure in Norwegian dairy herds. Acta Vet Scand. 2023. https://www.semanticscholar.org/paper/90d5bc7610aee259243e35ae1076bed890594417

[14] Bellet C, Green MJ, Bradley AJ, et al. A longitudinal study of gastrointestinal parasites in English dairy farms. Practices and factors associated with first lactation heifer exposure to Ostertagia ostertagi on pasture. J Dairy Sci. 2018. https://www.semanticscholar.org/paper/0209158606313c6ed5567f6c3119f5363ec9571d

[15] Berk Z, Laurenson Y, Forbes A, et al. Modelling the impacts of pasture contamination and stocking rate for the development of targeted selective treatment strategies for Ostertagia ostertagi infection in calves. Vet Parasitol. 2017. https://www.semanticscholar.org/paper/427d0b8da81af11e3b8b8ee1e39323034c0c65d7

[16] Fox MT, Uche U, Vaillant C, et al. Effects of Ostertagia ostertagi and omeprazole treatment on feed intake and gastrin-related responses in the calf. Vet Parasitol. 2002. https://www.semanticscholar.org/paper/5a76b7eb0e1389bb7aaee0d852c38e5759f78957

[17] Michel JF, Lancaster MB, Hong C, et al. Plasma pepsinogen levels in some experimental infections of Ostertagia ostertagi in cattle. Vet Rec. 1978. https://www.semanticscholar.org/paper/96071f8ad8cf6441ca694e2147fdf0a59a867ea3

[18] Markovits JE. Effect of Experimental Ostertagia ostertagi Infection or Chronic Pentagastrin Treatment on Abomasal Pathophysiology and Morphology of Goats. 1986. https://www.semanticscholar.org/paper/f575ec1b330f347e65ab7bd8a2ece6c796ce91b0

[19] Banks AW, Mitton RL. Acute Ostertagia ostertagi infection in young cattle and its successful treatment with O,O-di-methyl 2,2,2-trichloro 1-hydroxy methyl phosphonate. 1960. https://www.semanticscholar.org/paper/6b14be59b29bfb3bea5e31664301fa4fcb7de228

[20] Sánchez J, Dohoo I, Leslie K, et al. The use of an indirect Ostertagia ostertagi ELISA to predict milk production response after anthelmintic treatment in confined and semi-confined dairy herds. Vet Parasitol. 2005. https://www.semanticscholar.org/paper/8b3c6a3112c6e5ecf21e47b026ebe046f09def39

[21] Fanke J, Charlier J, Steppin T, et al. Economic assessment of Ostertagia ostertagi and Fasciola hepatica infections in dairy cattle herds in Germany using Paracalc. Vet Parasitol. 2017. https://www.semanticscholar.org/paper/9b18c4b5f4310a268fc883a63dc3ee7672229cfd

[22] Boschiero C, Liu GE, Tuo W. 201 Transcriptome analysis of bovine abomasal mucosa following experimental infection with Ostertagia ostertagi. J Anim Sci. 2024. https://www.semanticscholar.org/paper/6732182763871640727fec7194d793137f0f03b5

[23] Fleming DS, Bakshi M, Thompson P, et al. Transcriptomic Analysis of Peripheral Blood Mononuclear Cells During Ostertagia ostertagi Infection in Cattle Highlights a Generalized Host Immune Reaction. Biology. 2025. https://www.semanticscholar.org/paper/1c2c0841eedfc82f49997e34886119af8cd037d3

[24] Lima J, McNeilly TN, Auffret M, et al. Rumen microbiome profiles of dairy cattle are affected by the presence of, and vaccination against, the abomasal parasitic nematode Ostertagia ostertagi. Sci Rep. 2025. https://www.semanticscholar.org/paper/dd9d6eb4e70e39dcb00916c7cfbb437d372820aa

[25] Agneessens J, Claerebout E, Vercruysse J. The use of copro-antigen detection for diagnosis of Ostertagia ostertagi infections in cattle. 2001. https://www.semanticscholar.org/paper/358d64e9fb7ce190f922621ff8596d590cc24225

[26] Charlier J, Vercruysse J, Smith J, et al. Evaluation of anti-Ostertagia ostertagi antibodies in individual milk samples as decision parameter for selective anthelmintic treatment in dairy cows. Prev Vet Med. 2010. https://www.semanticscholar.org/paper/c19aee9ff0bed8718f8860d230f834debb4d7e85

[27] Florence C, Cogan T. Diagnosis and monitoring of anthelmintic resistant gastro-intestinal nematodes of UK cattle: Development of a qPCR on L1 larvae of O. ostertagi. 2014. https://www.semanticscholar.org/paper/8f5107ba3e00c47178006df92f879fad23493f25

[28] Edmonds MD, Johnson EG, Edmonds JD. Anthelmintic resistance of Ostertagia ostertagi and Cooperia oncophora to macrocyclic lactones in cattle from the western United States. Vet Parasitol. 2010. https://www.semanticscholar.org/paper/fa637f78cec94ced45d03bb8cb613e582d4cfe98

[29] Knapp-Lawitzke F, Krücken J, Ramünke S, et al. Rapid selection for β-tubulin alleles in codon 200 conferring benzimidazole resistance in an Ostertagia ostertagi isolate on pasture. Vet Parasitol. 2015. https://www.semanticscholar.org/paper/f70397bc5f708321c24f0bc71f0239e497514b9b

[30] Anderson N. The efficiency of levamisole, thiabendazole and fenbendazole against naturally acquired infections of Ostertagia ostertagi in cattle. Res Vet Sci. 1977. https://www.semanticscholar.org/paper/051dce825901c27100e1ac3914bc33d504ccfde9

[31] Tuo W, Zarlenga D, Bakshi M, et al. Repeated, drug-truncated infections with Ostertagia ostertagi elicit strong humoral and cell-mediated immune responses and confer partial protection in cattle. Vet Parasitol. 2021. https://www.semanticscholar.org/paper/5adeb219015707f6398f40b59845e490736890f1

[32] Claerebout E, Hilderson H, Meeus P, et al. The effect of truncated infections with Ostertagia ostertagi on the development. 2017. https://www.semanticscholar.org/paper/db552143d69ae0197462528a279ba0355e15c5ba

[33] Szyszka O, Tolkamp BJ, Edwards SA, et al. Do the changes in the behaviours of cattle during parasitism with Ostertagia ostertagi have a potential diagnostic value? Vet Parasitol. 2013. https://www.semanticscholar.org/paper/4425feb9400d14c3f8ad6cfb813bbfcb4de97248

[34] Michel JF, Sinclair IJ. The effect of cortisone on the worm burdens of calves infected daily with Ostertagia ostertagi. Parasitology. 1969. https://www.semanticscholar.org/paper/e96f1c8cabd9c987f1c03daa106a2220e3c335ed

[35] Yagoob G, Mirhadi K, Branch T. The effect of ivermectin pour-on administration against natural Ostertagia ostertagi infestations and prevalence rate of that in cattle. 2014. https://www.semanticscholar.org/paper/8c627db942320745c7ffbd15e17ef41bd557d813